Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
The Australasian Journal of Dermatology|September 25, 2023
Upadacitinib effectiveness in moderate-to-severe atopic dermatitis: A real-life multicentre and retrospective studyF Javier Melgosa Ramos, Víctor González-Delgado, José María Sánchez Motilla, et al.Dermatology Online Journal|May 4, 2019
Exogenous ochronosis: the failure of depigmenting creamsEva María Sánchez-Martínez, María Isabel García-Briz, Lya Magdalena Moneva-Léniz, et al.Dermatology Online Journal|May 4, 2019
Endogenous ochronosis: when clinical suspicion prevails over histopathologyEva María Sánchez-Martínez, María Isabel García-Briz, Lya Magdalena Moneva-Léniz, et al.Pharmaceutics|March 26, 2022
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of PsoriasisKarine Rodríguez-Fernández, Víctor Mangas-Sanjuán, Matilde Merino-Sanjuán, et al.Annals of Medicine|April 4, 2023
Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature reviewIsabel Belinchon Romero, Almudena Mateu Puchades, Miguel Ribera Pibernat, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 9, 2024
Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosisClara Cortell-Fuster, María Amparo Martínez-Gómez, Ana Cristina Cercós-Lleti, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|February 15, 2025
Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosisClara Cortell-Fuster, María Amparo Martínez-Gómez, Ana Cristina Cercós-Lleti, et al.International Journal of Dermatology|March 3, 2024
Psoriasis dermatitis, a common phenotype of early forms of both psoriasis and atopic dermatitis in children: A prospective multicenter studyAlexandre Docampo-Simón, Isabel Belinchón, María J Sánchez-Pujol, et al.Pharmaceutics|January 8, 2025
Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision DosingKarine Rodriguez-Fernandez, Javier Zarzoso-Foj, Marina Saez-Bello, et al.Pharmaceutics|October 26, 2024
Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque PsoriasisKarine Rodríguez-Fernández, Javier Zarzoso-Foj, Marina Saez-Bello, et al.Pageof 3